Relapse of autoimmune diseases after liver transplantation

Background. The recurrence of autoimmune liver diseases can lead to reduced survival recipients and grafts.Aim. To study the incidence impact on graft survival; effect maintenance immunosuppression in transplant recipientsMaterial methods. Transplantation outcomes 111 (21 operated for hepatitis, 50 primary biliary cirrhosis, 40 sclerosing cholangitis) were analyzed retrospectively.Results. hepatitis is observed 5%, cirrhosis 10%, cholangitis 17% cases. Among patients with diseases, men accounted 54%, while only 31% subgroup without relapse (p=0.004). followup (64.5 (42.8;82.0) months) was comparable follow-up (46.5 (17.9;103.5) months, p=0.54). A ten-year significantly higher group recurrent compared (p<0.0001).Conclusions. leads a decrease survival. components risk has not been established.